NasdaqCM - Nasdaq Real Time Price USD
FibroBiologics, Inc. (FBLG)
0.9560
+0.1018
+(11.92%)
At close: June 6 at 4:00:00 PM EDT
0.9255
-0.03
(-3.19%)
After hours: June 6 at 7:53:37 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 2 | 2 | 2 | 2 |
Avg. Estimate | -0.12 | -0.12 | -0.47 | -0.54 |
Low Estimate | -0.12 | -0.12 | -0.49 | -0.6 |
High Estimate | -0.12 | -0.12 | -0.46 | -0.48 |
Year Ago EPS | -- | -- | -0.34 | -0.47 |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | -- | -- | -- | -- |
Low Estimate | -- | -- | -- | -- |
High Estimate | -- | -- | -- | -- |
Year Ago Sales | -- | -- | -- | -- |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
---|---|---|---|---|
EPS Est. | -0.09 | -0.09 | -0.07 | -0.12 |
EPS Actual | 0.03 | -0.01 | -0.09 | -0.14 |
Difference | 0.12 | 0.08 | -0.02 | -0.02 |
Surprise % | 133.33% | 88.46% | -28.57% | -12.00% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -0.12 | -0.12 | -0.47 | -0.54 |
7 Days Ago | -0.12 | -0.12 | -0.48 | -0.53 |
30 Days Ago | -0.12 | -0.12 | -0.48 | -0.53 |
60 Days Ago | 0 | 0 | -0.26 | -0.39 |
90 Days Ago | 0 | 0 | -0.26 | -0.39 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
FBLG | -- | -- | -39.71% | -13.68% |
S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
Maintains | D. Boral Capital: Buy to Buy | 5/15/2025 |
Maintains | D. Boral Capital: Buy to Buy | 4/9/2025 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
Maintains | D. Boral Capital: Buy to Buy | 4/1/2025 |
Maintains | D. Boral Capital: Buy to Buy | 3/4/2025 |
Maintains | D. Boral Capital: Buy to Buy | 2/27/2025 |
Related Tickers
JUNS Jupiter Neurosciences, Inc.
0.7804
-3.89%
CNTX Context Therapeutics Inc.
0.6641
+20.40%
CLDI Calidi Biotherapeutics, Inc.
0.3560
-0.17%
IMUX Immunic, Inc.
0.7884
+2.01%
TELO Telomir Pharmaceuticals, Inc.
2.1500
+6.97%
ZVSA ZyVersa Therapeutics, Inc.
0.6549
+1.50%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.8215
+2.69%
ABP Abpro Holdings, Inc.
0.2103
-0.94%
APVO Aptevo Therapeutics Inc.
4.9500
+3.56%
RANI Rani Therapeutics Holdings, Inc.
0.5600
+5.88%